Nigel Crockett is CHIEF BUSINESS OFFICER at BICYCLE THERAPEUTICS PLC (BCYC). They have made 10 open-market trades across 1 company since 2021, most recently 2025-01-03.
CIK 0001788580
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BCYC | 51,989 | $193K |
Shares reported on the most recent Form 4, priced at the 2025-01-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BCYC | SELL | 2025-01-02 | 2025-01-06 | $14.27 | $50K | -11.0% | -14.1% | -55.0% |
| BCYC | SELL | 2024-10-03 | 2024-10-04 | $22.26 | $22K | +18.2% | +0.8% | -38.3% |
| BCYC | SELL | 2024-07-03 | 2024-07-08 | $19.64 | $19K | +12.5% | +12.4% | +16.7% |
| BCYC | SELL | 2024-04-03 | 2024-04-05 | $23.81 | $23K | -4.0% | +2.5% | -11.1% |
| BCYC | SELL | 2024-01-03 | 2024-01-04 | $17.50 | $46K | +7.4% | +0.2% | +37.5% |
| BCYC | SELL | 2023-10-03 | 2023-10-05 | $20.00 | $9K | -8.8% | -30.7% | -18.2% |
| BCYC | SELL | 2023-07-03 | 2023-07-06 | $25.10 | $11K | +2.1% | -5.4% | -18.4% |
| BCYC | SELL | 2023-04-03 | 2023-04-05 | $21.11 | $9K | -7.5% | +2.8% | +16.9% |
| BCYC | SELL | 2023-01-03 | 2023-01-05 | $29.06 | $105K | -10.9% | -8.4% | -31.3% |
| BCYC | SELL | 2021-07-12 | 2021-07-14 | $32.40 | $5.2M | +2.9% | -14.7% | +62.7% |
| BCYC | SELL · 10b5-1 | 2021-07-06 | 2021-07-08 | $32.00 | $9K | +9.7% | -3.7% | +32.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.